ElinaMyxlik's profile picture.

Elina

@ElinaMyxlik

Joined December 2015
Similar User
PSMAconference's profile picture. Conference focused on theranostics. 2025 conference will be held in Los Angeles on March 28-29.  Co-sponsored by UCLA/UCSF/PCF.

@PSMAconference

MariaBelmonte95's profile picture. Radiation oncology ☢️ resident at Fondazione IRCCS San Gerardo dei Tintori 🇮🇹 @unimib.

@MariaBelmonte95

dr_kazi1's profile picture. Consultant Hemato-oncologist and BMT Physician

@dr_kazi1

mat_sepu's profile picture. Radiation Oncologist, main focus on prostate and lung. Basketball lover. #radonc

@mat_sepu

AquinoHolanda's profile picture. Medical Oncologista - Real Hospital Português 🇧🇷 Medical Oncologist

@AquinoHolanda

PaolaAnselmo7's profile picture. Radiation Oncologist, S. Maria Hospital, Terni

@PaolaAnselmo7

SwayamjeetNM's profile picture. Senior Resident, Department of Nuclear Medicine, AIIMS, New Delhi

@SwayamjeetNM

Elina Reposted

What happened in breast cancer in 2024? A summary of important studies👇 #bcsm

's tweet image. What happened in breast cancer in 2024? 

A summary of important studies👇

#bcsm
's tweet image. What happened in breast cancer in 2024? 

A summary of important studies👇

#bcsm
's tweet image. What happened in breast cancer in 2024? 

A summary of important studies👇

#bcsm
's tweet image. What happened in breast cancer in 2024? 

A summary of important studies👇

#bcsm

Elina Reposted

PET/CT scans in pregnancy result in low fetal radiation exposure (1.2–8.2 mGy), well below thresholds for deterministic effects (50–100 mGy). Always modify protocols to minimise exposure.

's tweet image. PET/CT scans in pregnancy result in low fetal radiation exposure (1.2–8.2 mGy), well below thresholds for deterministic effects (50–100 mGy). Always modify protocols to minimise exposure.

Elina Reposted

Do all early-stage breast cancer patients need axillary surgery? The INSEMA trial challenges this long-standing practice, showing that skipping sentinel lymph node biopsy (SLNB) may be safe for select patients. ☢️ plays a key role. Let’s dive into the data. 🧵 1/13#RadOnc

's tweet image. Do all early-stage breast cancer patients need axillary surgery? The INSEMA trial challenges this long-standing practice, showing that skipping sentinel lymph node biopsy (SLNB) may be safe for select patients. ☢️ plays a key role. Let’s dive into the data. 🧵 1/13#RadOnc…

Elina Reposted

What is my 2025 prediction for Lu-PSMA? ... Pre-chemotherapy approval

THE HISTORY OF PSMA THERANOSTICS in this months @JournalofNucMed jnm.snmjournals.org/content/63/3/3… I think the 2022 headline will be FDA approval of Lu-177 PSMA-617 @PCF_Science @soulehoward1 @AndreaMiyahira @pros_tic

DrMHofman's tweet image. THE HISTORY OF PSMA THERANOSTICS in this months @JournalofNucMed jnm.snmjournals.org/content/63/3/3…
I think the 2022 headline will be FDA approval of Lu-177 PSMA-617
@PCF_Science @soulehoward1 @AndreaMiyahira @pros_tic


Elina Reposted

Should Lu-PSMA radiopharmaceutical therapy be used in earlier lines of therapy rather than after an ARPI or docetaxel? @ASCO Daily News: dailynews.ascopubs.org/do/integrating… @AzadOncology


Elina Reposted

A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 sciencedirect.com/science/articl… NOW ON FINAL SESSION of #PROSCA24 The 2024 Advanced Prostate Cancer Consensus Conference (APCCC)…

's tweet image. A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24

LINK TO ARTICLE👇👇👇👇👇👇👇👇
sciencedirect.com/science/articl…

NOW ON FINAL SESSION of #PROSCA24

The 2024 Advanced Prostate Cancer Consensus Conference (APCCC)…

Elina Reposted

The Theranostics Dream will enter a new chapter youtu.be/qaB7AjZ7PpE?fe… via @YouTube with this new @GEHealthCare @PeterMacCC collaboration gehealthcare.com/about/newsroom…


Elina Reposted

Thrilled to lead this transformative project to accelerate development of novel radiotracers for PET scanning and therapy! Thank-you @Cancer_Research @UniMelb @NIFAus @ocrfaustralia @GEHealthCare Collaborators @LindaMileshkin @LucFuric @MHaskali @ProfKHerrmann @pj_physics

's tweet image. Thrilled to lead this transformative project to accelerate development of novel radiotracers for PET scanning and therapy! 

Thank-you @Cancer_Research @UniMelb @NIFAus @ocrfaustralia @GEHealthCare 

Collaborators @LindaMileshkin @LucFuric @MHaskali @ProfKHerrmann @pj_physics…
This post is unavailable.

Elina Reposted

The expression level of FAP in castration-resistant prostate cancer (CRPC) is generally low, suggesting limited value for FAPi PET imaging in CRPC patients. ow.ly/C8h950U4BX0 #NuclearMedicine #ProstateCancer #PETscan @calaisjeremie @czerninjohannes

's tweet image. The expression level of FAP in castration-resistant prostate cancer (CRPC) is generally low, suggesting limited value for FAPi PET imaging in CRPC patients. ow.ly/C8h950U4BX0 

#NuclearMedicine #ProstateCancer #PETscan @calaisjeremie @czerninjohannes

Elina Reposted

¹⁷⁷Lu-PSMA SPECT/CT at 4 hours after injection appears a promising alternative to 24-hour ¹⁷⁷Lu-PSMA SPECT/CT for treatment response assessment, with improved patient convenience. ow.ly/7ZEa50U4BT9 #NuclearMedicine #ProstateCancer @DrMSwiha @drlouiseemmett

's tweet image. ¹⁷⁷Lu-PSMA SPECT/CT at 4 hours after injection appears a promising alternative to 24-hour ¹⁷⁷Lu-PSMA SPECT/CT for treatment response assessment, with improved patient convenience. ow.ly/7ZEa50U4BT9

#NuclearMedicine #ProstateCancer @DrMSwiha @drlouiseemmett

Elina Reposted

Intraarterial PRRT in patients with advanced meningioma is feasible and safe, and may result in improved radiologic and clinical disease control compared with intravenous PRRT. ow.ly/cRvy50TWafj #NuclearMedicine #Theranostics #Meningioma

's tweet image. Intraarterial PRRT in patients with advanced meningioma is feasible and safe, and may result in improved radiologic and clinical disease control compared with intravenous PRRT. ow.ly/cRvy50TWafj

#NuclearMedicine #Theranostics #Meningioma

Elina Reposted

A scientist treated her own cancer, then published the findings. 🧵1/12

's tweet image. A scientist treated her own cancer, then published the findings.

🧵1/12

Elina Reposted

"Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom ➡️SABR to median=16 "poly"metastases in patients who had already exhausted multiple lines of systemic therapy ➡️4x dose levels (up to 6Gyx5). ➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏

's tweet image. "Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom 
➡️SABR to median=16 "poly"metastases in patients  who had already exhausted multiple lines of systemic therapy
➡️4x dose levels (up to 6Gyx5). 
➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏
's tweet image. "Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom 
➡️SABR to median=16 "poly"metastases in patients  who had already exhausted multiple lines of systemic therapy
➡️4x dose levels (up to 6Gyx5). 
➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏
's tweet image. "Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom 
➡️SABR to median=16 "poly"metastases in patients  who had already exhausted multiple lines of systemic therapy
➡️4x dose levels (up to 6Gyx5). 
➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏
's tweet image. "Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom 
➡️SABR to median=16 "poly"metastases in patients  who had already exhausted multiple lines of systemic therapy
➡️4x dose levels (up to 6Gyx5). 
➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏

Elina Reposted

💊Aspirin (ASA) and NSAID Chemoprevention Uptake in Patients With Lynch Syndrome @JCOPO_ASCO 🚨Uptake is 34.8% 🚨55% were taking <100 mg ASA ➡️CAPP2 randomized double-blind placebo-controlled trial: 60% RR reduction for CRC with 600mg ASA 👉doi.org/10.1200/PO-24-… @ASCO

's tweet image. 💊Aspirin (ASA) and NSAID Chemoprevention Uptake in Patients With Lynch Syndrome
@JCOPO_ASCO 

🚨Uptake is 34.8%
🚨55% were taking &amp;lt;100 mg ASA

➡️CAPP2 randomized double-blind placebo-controlled trial: 60% RR reduction for CRC with 600mg ASA

👉doi.org/10.1200/PO-24-…

@ASCO…
's tweet image. 💊Aspirin (ASA) and NSAID Chemoprevention Uptake in Patients With Lynch Syndrome
@JCOPO_ASCO 

🚨Uptake is 34.8%
🚨55% were taking &amp;lt;100 mg ASA

➡️CAPP2 randomized double-blind placebo-controlled trial: 60% RR reduction for CRC with 600mg ASA

👉doi.org/10.1200/PO-24-…

@ASCO…

Elina Reposted

#RADIOSA Trial: SBRT vs SBRT+ADT for oligorecurrent #ProstateCancer. @GiuliaMarvaso84 shares findings from the RADIOSA trial, comparing SBRT alone vs. SBRT + short-course hormonal therapy in oligorecurrent #PCa. Results show enhanced biochemical and clinical progression-free…

's tweet image. #RADIOSA Trial: SBRT vs SBRT+ADT for oligorecurrent #ProstateCancer. @GiuliaMarvaso84 shares findings from the RADIOSA trial, comparing SBRT alone vs. SBRT + short-course hormonal therapy in oligorecurrent #PCa. Results show enhanced biochemical and clinical progression-free…
's tweet image. #RADIOSA Trial: SBRT vs SBRT+ADT for oligorecurrent #ProstateCancer. @GiuliaMarvaso84 shares findings from the RADIOSA trial, comparing SBRT alone vs. SBRT + short-course hormonal therapy in oligorecurrent #PCa. Results show enhanced biochemical and clinical progression-free…
's tweet image. #RADIOSA Trial: SBRT vs SBRT+ADT for oligorecurrent #ProstateCancer. @GiuliaMarvaso84 shares findings from the RADIOSA trial, comparing SBRT alone vs. SBRT + short-course hormonal therapy in oligorecurrent #PCa. Results show enhanced biochemical and clinical progression-free…
's tweet image. #RADIOSA Trial: SBRT vs SBRT+ADT for oligorecurrent #ProstateCancer. @GiuliaMarvaso84 shares findings from the RADIOSA trial, comparing SBRT alone vs. SBRT + short-course hormonal therapy in oligorecurrent #PCa. Results show enhanced biochemical and clinical progression-free…

Elina Reposted

📣Urologic Imaging of the Prostate: Cancer and Mimics 🔷Excellent review article with amazing case samples by @mharisinghani and his colleagues! 👍Congratulations to all Authors 🔖A must read document to learn more about #prostateMRI #TeamScience #Radiology

's tweet image. 📣Urologic Imaging of the Prostate: Cancer and Mimics
🔷Excellent review article with amazing case samples by @mharisinghani  and his colleagues!
👍Congratulations to all Authors
🔖A must read document to learn more about #prostateMRI 
#TeamScience #Radiology…
's tweet image. 📣Urologic Imaging of the Prostate: Cancer and Mimics
🔷Excellent review article with amazing case samples by @mharisinghani  and his colleagues!
👍Congratulations to all Authors
🔖A must read document to learn more about #prostateMRI 
#TeamScience #Radiology…
's tweet image. 📣Urologic Imaging of the Prostate: Cancer and Mimics
🔷Excellent review article with amazing case samples by @mharisinghani  and his colleagues!
👍Congratulations to all Authors
🔖A must read document to learn more about #prostateMRI 
#TeamScience #Radiology…
's tweet image. 📣Urologic Imaging of the Prostate: Cancer and Mimics
🔷Excellent review article with amazing case samples by @mharisinghani  and his colleagues!
👍Congratulations to all Authors
🔖A must read document to learn more about #prostateMRI 
#TeamScience #Radiology…

Elina Reposted

Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† annalsofoncology.org/article/S0923-…

's tweet image. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† 

annalsofoncology.org/article/S0923-…
's tweet image. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† 

annalsofoncology.org/article/S0923-…
's tweet image. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† 

annalsofoncology.org/article/S0923-…
's tweet image. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† 

annalsofoncology.org/article/S0923-…

Elina Reposted

Findings of I-131 SPECT/CT, 18F-FDG, and 68Ga-FAPI-04 PET/ CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma You can see the free full text of the research by Gamze Tatar et al. Link : mirt.tsnmjournals.org/articles/findi…

's tweet image. Findings of I-131 SPECT/CT, 18F-FDG, and 68Ga-FAPI-04 PET/ CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma

You can see the free full text of the research by Gamze Tatar et al.

Link : mirt.tsnmjournals.org/articles/findi…

Elina Reposted

🧬 Non-G12C KRAS mutations 🧬 @Annals_Oncology #ESMO24 📌 H & N SCC 📌 Lung adeno 📌 Cutaneous melanoma 📌 Thyroid 📌 PDAC 📌 Colorectal 📌 Bladder urothelial @KRASKickers #Ras

's tweet image. 🧬 Non-G12C KRAS mutations 🧬

@Annals_Oncology
#ESMO24

📌 H &amp;amp; N SCC
📌 Lung adeno
📌 Cutaneous melanoma
📌 Thyroid
📌 PDAC
📌 Colorectal
📌 Bladder urothelial

@KRASKickers
#Ras

Elina Reposted
's tweet image.

Loading...

Something went wrong.


Something went wrong.